Copyright
©The Author(s) 2015.
World J Hepatol. Apr 8, 2015; 7(4): 649-661
Published online Apr 8, 2015. doi: 10.4254/wjh.v7.i4.649
Published online Apr 8, 2015. doi: 10.4254/wjh.v7.i4.649
Ref. | Name of criteria | No. of nodules | Diameter | Tumour different | PIVKA-II | Prospective validation | n | Outcomes within Milan criteria | Outcomes within proposed criteria | P |
Mazzaferro et al[13] | Milan | 1 or ≤ 3 | ≤ 5 cm or ≤ 3 cm each | - | - | + | 48 | 4-yr survival rate 75% 4-yr recurrence free survival rate 83% | NA | |
Mazzaferro et al[16] | Up-to-seven | TTN + DLN ≤ 7 | - | - | +[139-141] | 1556 | 5-yr survival rate 73.3% | 5-yr survival rate 71.2% | > 0.05 | |
Yao et al[18] | UCSF criteria | 1 or ≤ 3 | ≤ 6.5 cm or ≤ 4.5 cm the largest one but with a TTD ≤ 8 cm | - | - | +[21] | 70 | 5-yr survival rate 72.4% | 5-yr survival rate 75.2% | 0.87 |
Herrero et al[23] | Universidad de Navarra criteria | 1 or 2-3 | ≤ 6 cm or ≤ 5 cm | - | - | - | 47 | Not reported | 5-yr survival rate 79% 3-yr recurrence free survival rate 70% | - |
Lee et al[32] | Asan criteria | ≤ 6 | ≤ 5 cm | - | - | - | 221 | 5-yr survival rate 76% 3-yr recurrence rate 13.6% | 5-yr survival rate 81.6% 3-yr recurrence rate 9.1% | 0.334 0.554 |
DuBay et al[27] | Toronto criteria | No | No | + | - | - | 294 | 5-yr overall survival rate 72% 5-yr disease free survival rate 70% | 5-yr overall survival rate 70% 5-yr disease free survival 66% | 0.63 0.25 |
Ito et al[24] | Kyoto criteria | ≤ 10 | ≤ 5 cm | - | + | - | 125 | Not reported | 5-yr survival 86.7% 5-yr recurrence 4.9% | - |
- Citation: Guerrero-Misas M, Rodríguez-Perálvarez M, De la Mata M. Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World J Hepatol 2015; 7(4): 649-661
- URL: https://www.wjgnet.com/1948-5182/full/v7/i4/649.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i4.649